Recombinant- follicle stimulating hormone (r-FSH) plus recombinant-luteinizing hormone (rLH)	Human menopausal gonadotropin (HMG) plus r-FSH	Number of oocytes or M2 oocytes	11983	12089	total number of oocytes or M2 oocytes and quality of fetuses has no significant differences between groups
Recombinant- follicle stimulating hormone (r-FSH) plus recombinant-luteinizing hormone (rLH)	Human menopausal gonadotropin (HMG) plus r-FSH	Number of follicles	1394	1546	Number of follicles in ovaries, total number of oocytes or M2 oocytes and quality of fetuses has no significant differences between two groups (p>0.05).
Recombinant- follicle stimulating hormone (r-FSH) plus recombinant-luteinizing hormone (rLH)	Human menopausal gonadotropin (HMG) plus r-FSH	Quality of fetuses	1394	1546	Number of follicles in ovaries, total number of oocytes or M2 oocytes and quality of fetuses has no significant differences between two groups (p>0.05).
Recombinant- follicle stimulating hormone (r-FSH) plus recombinant-luteinizing hormone (rLH)	Human menopausal gonadotropin (HMG) plus r-FSH	Total number of fetuses	1547	1642	Total number of fetuses were significantly higher in patients who received rFSH + HMG (p=0.02).
Recombinant- follicle stimulating hormone (r-FSH) plus recombinant-luteinizing hormone (rLH)	Human menopausal gonadotropin (HMG) plus r-FSH	Total number of fetuses	12096	12182	total number of fetuses was significantly higher in patients who received rFSH and HMG
Recombinant- follicle stimulating hormone (r-FSH) plus recombinant-luteinizing hormone (rLH)	Human menopausal gonadotropin (HMG) plus r-FSH	Fertility outcomes	1643	1815	Fertility outcomes consisted of: live birth rate, chemical pregnancy and clinical pregnancy rate were higher in rFSH + HMG group in comparison to rFSH +r-LH group (p<0.05).
Recombinant- follicle stimulating hormone (r-FSH) plus recombinant-luteinizing hormone (rLH)	Human menopausal gonadotropin (HMG) plus r-FSH	Number of oocytes or M2 oocytes	1394	1546	Number of follicles in ovaries, total number of oocytes or M2 oocytes and quality of fetuses has no significant differences between two groups (p>0.05).
